Earnings release · DHR
Danaher Corp. · Filed · SEC Form 8-K, Item 2.02
Revenue increased 8.5% year on year to $6.6 billion. The company revised its guidance; the original release shows which items moved and by how much.
Written automatically by Stocknote's note engine from the figures on this page and the company's previous release. Every number in this note is checked against those figures. Not investment advice.
$6.6 billion +8.5% vs a year ago
…Revenues increased 8.5% year-over-year to $6.6 billion.…
Guidance revised
…For full year 2026, the Company is increasing its full year adjusted diluted net earnings per common share guidance to a range of $8.57 to $8.62 versus previous guidance of $8.45 to $8.60.…
Danaher's Q3 core sales rose 3% and adjusted EPS 11.5%, but a swing in income tax supplied about 81% of the net earnings increase, and respiratory testing sales fell about 30%.
Forensic equity research on US stocks. No spam, unsubscribe anytime.
